The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...
The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, ...
AstraZeneca released results from the TROPION-Breast01 Phase 3 trial of datopotamab deruxtecan, showing no statistically ...
A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and ...
James Gordon has given his Buy rating due to a combination of factors surrounding AstraZeneca’s position in the market and the assessment of their drug development pipeline. Firstly, despite the final ...
The U.S. Food and Drug Administration (FDA) has approved FluMist for self-administration. On Friday, the FDA announced that ...
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
Recent health developments include the EU backing Novo Nordisk's Wegovy for obesity-related heart conditions, FDA approvals ...
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first “self-administered” influenza vaccine — though a delay in the change ...
The AstraZeneca vaccine FluMist, which is administered in nasal spray form, was first approved by the FDA in 2003 for people ...
AstraZeneca's FluMist influenza vaccine, which can be self-administered. Experts hope an option for at-home flu vaccination ...
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.